A Superhydrophilic, Light/Microwave-Absorbing Coating with Remarkable Antibacterial Efficacy.

Driven by the overuse of antibiotics, pathogenic infections, dominated by the rapid emergence of antibiotic resistant bacteria, have become one of the greatest current global health challenges. Thus, there is an urgent need to explore novel strategies that integrate multiple antibacterial modes to deal with bacterial infections. In this work, a Co(Ni,Ag)/Fe(Al,Cr)O composite duplex coating was fabricated using template-free sputtering deposition technology. The phase constitution of the coating was estimated to be 79 wt % Fe(Al,Cr)O phase and 21 wt % of an Ag-containing metallic phase. The composite coating consisted of a ∼10 μm-thick porous outer-layer and a ∼6 μm-thick compact inner-layer, in which the outer-layer is composed of a densely stacked array of microscale cones. After exposure to ambient air for 14 days, the composite coating showed a wettability transition from a superhydrophilic nature to exhibit adhesive superhydrophobic behavior with a water contact angle of 142° ± 2.8°, but it reverted to its initial superhydrophilic state after annealing in air at 200 °C for 5 h. The absorption rate of the as-received composite coating exceeds 99% in a broad band spanning both the visible and NIR regions and showed a high photothermal efficiency to convert photon energy into heat. Similarly, the composite coating showed microwave absorption behavior with a minimum reflection loss value of 38 dB at 4.4 GHz. In vitro antibacterial tests were used to determine the antibacterial behavior of the composite coating against and after 60 min of visible light irradiation. After this exposure, the as-prepared composite coating exhibited nearly 100% bactericidal efficiency against these bacteria. The antibacterial behavior of the coating was attributed to the synergistic effects of the superhydrophilic surface, the release of Ag ions, and the photothermal effect. Therefore, this composite coating may be a promising candidate to efficiently combat medical device-associated infections.